LPL Financial LLC Has $18.48 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

LPL Financial LLC raised its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 21.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 61,581 shares of the company's stock after acquiring an additional 10,777 shares during the quarter. LPL Financial LLC's holdings in HCA Healthcare were worth $18,484,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Evergreen Private Wealth LLC raised its holdings in HCA Healthcare by 0.3% during the 4th quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock worth $3,838,000 after buying an additional 35 shares during the period. Mediolanum International Funds Ltd increased its stake in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after acquiring an additional 36 shares during the last quarter. Prairie Wealth Advisors Inc. boosted its position in HCA Healthcare by 6.1% during the fourth quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock valued at $210,000 after purchasing an additional 40 shares during the last quarter. Whittier Trust Co. increased its position in HCA Healthcare by 3.6% in the 4th quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock worth $359,000 after purchasing an additional 41 shares during the last quarter. Finally, Greenleaf Trust grew its stake in shares of HCA Healthcare by 0.8% in the 4th quarter. Greenleaf Trust now owns 5,771 shares of the company's stock valued at $1,732,000 after buying an additional 46 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Remove Ads

HCA Healthcare Price Performance

Shares of NYSE:HCA traded up $1.75 during midday trading on Wednesday, reaching $347.48. 1,249,318 shares of the company's stock were exchanged, compared to its average volume of 1,349,682. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The firm has a market capitalization of $85.55 billion, a PE ratio of 15.82, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. The company's 50 day simple moving average is $325.79 and its two-hundred day simple moving average is $340.25.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the business posted $5.90 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were paid a $0.72 dividend. The ex-dividend date of this dividend was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. This is a boost from HCA Healthcare's previous quarterly dividend of $0.66. HCA Healthcare's payout ratio is 13.11%.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the stock. Truist Financial dropped their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $380.00 price target on shares of HCA Healthcare in a research report on Tuesday, December 17th. Bank of America cut their price objective on HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. Cantor Fitzgerald reiterated an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Finally, Royal Bank of Canada lowered their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $385.67.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.